Systemic chemotherapy is the standard of care for the treatment of unresectable metastatic colorectal cancer. However, new drug delivery platforms are needed to mitigate its associated toxicities. In this study, we develop and evaluate a liposome formulation that deliver oxaliplatin under magnetic field stimulus site selectively release in high concentration to alleviate the off-target effects in a rat model of colorectal liver metastases (CRLM). Quantitative MRI enabled assessment of changes in tumor characteristics over time for confirmation of procedural success and proper catheter-selective tumor targeting, which allows for high concentrations of oxaliplatin and improves survival outcomes in CRLM tumor-bearing rats.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords